Jasper Therapeutics Inc. (JSPRW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.15
-0.02 (-11.56%)
At close: Jan 15, 2025, 12:42 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.11M | 1.31M | 566.00K | 21.00K | n/a |
Gross Profit | -1.11M | -1.31M | -566.00K | -21.00K | n/a |
Operating Income | -68.86M | -51.20M | -36.83M | -20.68M | -4.71M |
Interest Income | 5.20M | n/a | n/a | n/a | 533.00 |
Pretax Income | -66.09M | -37.69M | -30.64M | -31.67M | -4.99M |
Net Income | -64.47M | -24.17M | -23.98M | -31.67M | -4.99M |
Selling & General & Admin | 17.08M | 16.57M | 11.41M | 4.80M | 1.09M |
Research & Development | 51.78M | 34.63M | 25.42M | 15.88M | 3.62M |
Other Expenses | n/a | 586.00K | -80.00K | -111.00K | n/a |
Operating Expenses | 68.86M | 51.20M | 36.83M | 20.68M | 4.45M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68.86M | 51.20M | 36.83M | 20.68M | 4.45M |
Income Tax | -1.63M | -13.51M | -6.65M | -38.45K | -277 |
Shares Outstanding (Basic) | 10.44M | 3.65M | 1.14M | 277.07K | n/a |
Shares Outstanding (Diluted) | 10.44M | 3.65M | 1.14M | 277.07K | n/a |
EPS (Basic) | -6.18 | -6.63 | -21.05 | -114.3 | n/a |
EPS (Diluted) | -6.18 | -6.63 | -21.05 | -114.3 | n/a |
EBITDA | -64.98M | -38.21M | -31.17M | -31.95M | -277.00K |
Depreciation & Amortization | 1.11M | 1.31M | 566.00K | 21.00K | 4.71M |